Share

Related Links

Related Stories

  • Drug Delivery – enabling technology for drug discovery and development
    Although drug delivery may not attract the attention and press coverage of some of the other disciplines involved in drug discovery, it is equally important in the development of a successful product. Effective drug delivery can be the difference between getting a molecule into clinical trial rather than a chemical sitting in a brown bottle on the shelf, or a forgotten compound languishing in a 96 well storage plate. It can mean the difference between a drug that just wipes its feet in the market and the discovery of a blockbuster.
  • Babraham scientists reveal how white blood cells get activated in auto-immune disease, helping to target better drugs for these disorders
    Scientists at the Babraham Institute have discovered a critical piece of the jigsaw that explains how a type of immune cell – a white blood cell known as a neutrophil – is activated by antibodies. The research, published today in the journal Science Signaling, brings new understanding to how the Phosphatidylinositol 3-kinase (PI3K) signalling pathway is used to regulate neutrophil function. This may pave the way for the development of a strategy to specifically inhibit the inappropriate activation of these immune cells that is seen in auto-immune inflammatory conditions such as rheumatoid arthritis, glomerulonephritis and some skin blistering diseases.
  • Why stem cells don't just want to make neurons
    Research being presented today (01 April) at the UK National Stem Cell Network annual science conference provides another piece in the puzzle of why it can be so hard to produce large numbers of the same type of cell in the lab - a process that is vital for scaling up stem cell production for therapeutic use. This knowledge will help researchers to develop strategies for obtaining the desired cell type for use in either research or medicine.
  • Scientists develop novel method to generate functional hepatocytes for drug testing
    Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell technology.
  • New alliance for discovery of WNT pathway inhibitors to be used in cancer therapy
    Cancer Research Technology, Merck Serono, Cancer Research UK, Cardiff University and The Institute of Cancer Research are set to begin a new research collaboration that will provide substantial investment in research on the WNT signalling pathway in the hope of finding new drug targets.

Top 5 Stories

News

'Spaghetti' scaffolding could help grow skin in labs

20 October 2009

Scientists are developing new scaffolding technology that could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures.

The new structures are being developed by scientists from the University of Bristol, using proteins from alpha helices – one of the fundamental ways that strings of amino acids fold – to create long fibres called hydrogelating self-assembling fibres (hSAFs), or hydrogels. By learning how to build hSAFs from scratch, the researchers are starting to understand how they might use these 3D scaffolds to support the growth of nerves, blood vessels and cartilage tailored to the needs of individual patients.

Professor Dek Woolfson, who is leading the work, explains: ‘To make hydrogels you need something long and thin that will interact with copies of itself and form meshes, but is also water soluble. However, rather than using natural proteins, which are complex, we've tried to make something as simple as possible that we fully understand using peptides and self-assembling proteins.’

Currently, hydrogel scaffold structures, made either synthetically or from natural resources such as seaweed, are used in everyday products from shampoos to drug capsules.

But, explains Professor Woolfson, the hSAFs his team are developing will have different uses: ‘The downside of using peptides or proteins is that they are expensive compared with synthetic polymers. We are almost certainly looking at high end biomedical applications, generating cells which can be used in living systems. Potential medical benefits include growing tissues such as skin, nerves and cartilage in the laboratory which will advance basic research and may lead to biomedical applications like speeding up wound healing and grafting.’

Commenting on the research, BBSRC Chief Executive Professor Doug Kell said: ‘This research highlights the importance of understanding how things work at a micro level and then looking at different ways to apply this knowledge to create effective solutions for tackling everyday problems: in this instance, translating basic bioscience into technology which could have very real clinical benefits for patients.’

This research is featured in the latest edition of Business, the quarterly magazine of BBSRC. The full article is available on the Business website.

 

This article is featured in:
Novel Technologies

 

Comment on this article

You must be registered and logged in to leave a comment about this article.